As of 2025-06-07, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (23.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1617.6%.
The range of the Relative Valuation is (19.79) - (30.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 20.5x | 13.8x |
| Forward P/E multiples | 11.1x - 17.8x | 13.6x |
| Fair Price | (19.79) - (30.43) | (23.37) |
| Upside | -1385.0% - -2076.3% | -1617.6% |
| Date | P/E |